Circulating serum micro-ribonucleic acids 155 and 205 before and after surgery in patients with breast cancer
- 1 January 2021
- journal article
- research article
- Published by Medknow in Journal of Clinical and Scientific Research
- Vol. 10 (2), 91
- https://doi.org/10.4103/jcsr.jcsr_44_20
Abstract
Background: Micro-ribonucleic acids (miRNAs) are small non-coding RNAs that regulate gene expression. Expression of miRNAs has been shown to be dysregulated in patients with breast cancer. These markers have been shown to be potential markers of diagnostic significance. We intended to study the usefulness of miRNA-155 and miRNA-205 in monitoring response to surgery by monitoring their pre- and post-operative expression. Methods: Twenty patients newly diagnosed with malignant breast disease along with 20 age-matched females not having any breast lesion were included in the study. Reverse transcription–polymerase chain reaction was used to assess the expression of circulating miRNAs. Results: MiRNA-155 was found to be significantly upregulated and miRNA-205 was significantly downregulated in patients with breast cancer compared to controls. There was no change in expression of miRNA-155 and miRNA-205 following surgery. Conclusions: The findings of the present study do not support the role of miRNA-155 and miRNA-205 as markers suitable for follow-up. However, the findings of the present study need to be confirmed in a larger sample size and samples collected over a defined post-operative period.Keywords
This publication has 21 references indexed in Scilit:
- Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast CancerPLOS ONE, 2012
- miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor statusOncology Letters, 2012
- Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancerMolecular Oncology, 2012
- Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast CancerClinical Chemistry, 2011
- CA 15-3: Uses and limitation as a biomarker for breast cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 2010
- MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting theSuppressor of Cytokine Signaling 1GeneCancer Research, 2010
- Suppression of cell growth and invasion by miR-205 in breast cancerCell Research, 2009
- MicroRNA and cancer: Current status and prospectiveInternational Journal of Cancer, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerThe New England Journal of Medicine, 2004